Rituximab EfFicacy IN MyasthEnia Gravis (REFINE)

NCT05868837 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Myasthenia Gravis, Generalized

Interventions

DRUG: Rituximab
OTHER: Placebo

Sponsor

Fondazione Policlinico Universitario Agostino Gemelli IRCCS